| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10218345 | Transfusion and Apheresis Science | 2018 | 8 Pages |
Abstract
Stringent laboratory quality assurance programs and proficiency testing to improve the accuracy of FVIII measurement, the widespread use of PK assessment to fine-tune FVIII dosing, and new research to identify patient characteristics and other contributors to bleeding risk and complication development are essential to optimizing outcomes for patients with hemophilia A receiving FVIII prophylaxis.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Leonard A. Valentino, Peter L. Turecek, Herbert Gritsch, Saulius Butenas, Kenneth G. Mann,